Mesothelioma and radical multimodality therapy: who benefits?

Sugarbaker, D J

Mesothelioma and radical multimodality therapy: who benefits? [electronic resource] - Chest Jun 1995 - 345S-350S p. digital

Publication Type: Journal Article; Review

0012-3692

10.1378/chest.107.6_supplement.345s doi


Antineoplastic Agents--therapeutic use
Chemotherapy, Adjuvant
Clinical Trials as Topic
Humans
Mesothelioma--drug therapy
Pleural Neoplasms--drug therapy
Pneumonectomy
Radiotherapy, Adjuvant
Survival Rate